Sign in Subscribe
Medical equipment industry

Boehringer Mannheim Files $20 Million Damages Claim Against Ostex Inc.

Strategic Insights

— 1 min read

Boehringer Mannheim, a global leader in diagnostics and pharmaceuticals, has taken a significant step in its ongoing dispute with Ostex Inc. by filing a claim for damages exceeding $20 million. According to Werner Schaefer, President of Boehringer Mannheim's Laboratory Diagnostics Division, the company has fulfilled all contractual obligations in its joint distribution and research partnership with Ostex to develop a bone loss urine test, known as Osteomark(R). However, Ostex's refusal to provide necessary materials and support has led to significant delays and additional development costs, prompting Boehringer Mannheim to seek damages.

Key Takeaways:

  • Boehringer Mannheim has filed a claim against Ostex Inc. for damages exceeding $20 million, citing Ostex's breach of contract and refusal to provide necessary materials and support.
  • The claim is related to a joint partnership to develop a bone loss urine test, known as Osteomark(R).
  • Boehringer Mannheim has fulfilled all its contractual obligations, including making a major breakthrough in the development of an automated assay for Osteomark(R).
  • Ostex's actions have delayed the launch of Osteomark(R) by the second half of 1996, but will not prevent its eventual launch.
  • The claim includes damages for additional development costs, delays, and lost sales, which are estimated to be in excess of $20 million.
  • Boehringer Mannheim has a global presence with operating companies in more than 25 countries, sales in over 120 countries, and over 17,000 employees.

Statistics:

  • The claim for damages exceeds $20 million.
  • Boehringer Mannheim has annual sales of $3.4 billion.
  • The company has more than 17,000 employees worldwide.
  • Boehringer Mannheim hassales in over 120 countries.
  • The company operates in more than 25 countries.

Sources:

  • Boehringer Mannheim Group (1995, Dec 4). Boehringer Mannheim Group announces claim against Ostex Inc. HealthWire.
  • HealthWire (1995, Dec 4). Boehringer Mannheim Group announces claim against Ostex Inc.

Read more